Series A funding round for Ouro Medicines raising $120M in January 2025
Series A funding round for Ouro Medicines raising $120M in January 2025
| Investor | Firm Type | Partner |
|---|
NEALEAD | Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Robert Garland |
| Angel | Matthew McAviney |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$120M
Top Valuation
-
Ouro Medicines raised $120M in a Series A round.
The round was announced on 01/01/25.
The round was led by NEA, Norwest Venture Partners, TPG Life Sciences Innovation.